HCG (Human Chorionic Gonadotropin) Priming for Thin Endometrium in IVF (in Vitro Fertilization)

• Status: Unknown status
• Trial end date: 2014-01-01
• Target enrollment: 0
• Participant gender: Female

Summary

A thin endometrium is one of the most difficult problems encountered in assisted reproduction every day practice Regarding the proliferative phase, several ways of treatment have been undertaken to circumvent thin endometrium trying to increase thickness with questionable results.

The objective of the current study will be whether a daily dose of 150 IU (international units) of human chorionic gonadotropin (HCG) for seven days concomitant with estrogen administration in estrogen replacement cycles can increase the endometrial thickness and improve pregnancy outcome.

• Phase: Phase 4
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Universitair Ziekenhuis Brussel
• Collaborator: Human Reproduction & Genetics Foundation
• Treatments: Chorionic Gonadotropin

Criteria

Inclusion Criteria:

• (1) Less than 6mm endometrial thickness before, (2) at least two failed implantations before

Exclusion Criteria:

• Abnormal uterine cavity in Hysteroscopy